Order results by:
| Issue | Title | |
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... of medicines upon discharge from the hospital was 60%, after 3 years this indicator decreased to 41.4% (p<0.001 ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... . The age of post-COVID patients with CVMM was 73.7±9.6 years, without CVD – 49.4±12.4 years (p<0.001 ..." | ||
| Vol 12, No 2 (2016) | CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 | Abstract PDF (Eng) PDF (Eng) similar documents |
| I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov | ||
| "... plaques: r=0.46 (р<0.001) in the younger group and r=0.47 (р<0.001) in the older one. We didn’t find any ..." | ||
| Vol 15, No 6 (2019) | Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) | Abstract similar documents |
| O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova | ||
| "... to the control group (1.94 vs. 1.28; p <0.001). The main contribution to the total risk of fatal CVD in middle ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... and hypertriglyceridemia was similar in the compared groups of patients with MS regardless of the presence of gout (p<0.001 ..." | ||
| Vol 8, No 5 (2012) | HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... .5±0.5; p<0.001) HR according to 24-h ECG, after adjustment for main TRF for CVD (age, arterial ..." | ||
| Vol 17, No 6 (2021) | Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) | Abstract similar documents |
| S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina | ||
| "... of at least one CVD was about half of the entire cohort of patients. In patients with CVD before COVID-19 ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... a higher likelihood of coronary artery disease detected during angiography than women without BAC (p<0.001 ..." | ||
| Vol 14, No 5 (2018) | Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” | Abstract similar documents |
| N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich | ||
| "... .28-15.4, p<0.001), percutaneous coronary intervention (RR 9.84; 95%CI 2.02-48.06, p<0.005), disability ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... .7% (p=0.10), had a family history of premature CVD – 3.2% and 1.2% (p=0.01), and had ..." | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... to the initial level from 2.92±0.22 to 1.65±0.19 mmol/L (p<0.001; Δ45.31±3.61%) and down to 1.74±0.17 mmol/L ..." | ||
| Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
| "... Aim. To assess long-term sequelae of COVID-19 in hospitalized patients at 3 to 7 months after ..." | ||
| Vol 17, No 6 (2021) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... in patients with COVID-19 with high reliability increased the risk of death (OR 1.744, CI 1.348-2.256, p<0.001 ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... was 69 (62-77) years, women were significantly older than men (p<0.001). When analyzing the most ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... a higher risk of thromboembolic complications (CHA2DS2-VASc – 4.68±1.59 and 3.10±1.50; p<0.001 ..." | ||
| Vol 16, No 2 (2020) | Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry) | Abstract similar documents |
| E. Yu. Andreenkо, M. M. Loukianov, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, V. A. Dindikova, A. N. Makoveeva, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... CVD was significantly higher in men <55 years old than in women <65 years old (44.8 vs 37.7%; p<0.0001 ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... with the frequency of UA control (p<0.001). In patients with AH, an increase in the level of sUA was detected ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... cardiovascular surgery. There were 63 hospitalizations due to cardiovascular diseases (CVD). AF did not lead ..." | ||
| Vol 16, No 5 (2020) | Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years | Abstract similar documents |
| S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina | ||
| "... beats/min and BP≥140/90 mm Hg had the shortest life expectancy (p<0.001). Adding an increased HR to BP ..." | ||
| Vol 18, No 2 (2022) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... <0.001), and a significant increase in the number of patients with preserved LVEF (from 30 [50 ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... .3 mmol/L and 2.3 mmol/L, respectively (p<0.001). Deterioration in the dynamics of alanine ..." | ||
| Vol 14, No 5 (2018) | Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis | Abstract similar documents |
| E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova | ||
| "... values: DAS decreased from 4.6 (2.9; 1.9) to 1.6 (1.3; 1.9), p=0,001; HAQ from 0.93 (0.81; 1.31) to 0 ..." | ||
| Vol 15, No 6 (2019) | Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident | Abstract similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, K. G. Pereverzeva, E. Yu. Okshina, A. V. Zagrebelnyy, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... ] for 1 year 1.03; 95%CI 1.02-1.05; р<0.001), female sex (IRR 2.40; 95%CI 1.79-3.23; р<0.001), COPD (IRR 2 ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... components according to multifactor origin of cardiovascular disease (CVD). Correction of lipid metabolism ..." | ||
| Vol 13, No 4 (2017) | PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) | Abstract similar documents |
| M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov | ||
| "... cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..." | ||
| Vol 15, No 1 (2019) | Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova | ||
| "... (CVD), non-CVD, all causes. A total of 10,650 deaths were registered: 8,726 in men (for 10 years) and 1 ..." | ||
| Vol 15, No 2 (2019) | Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital | Abstract similar documents |
| A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda | ||
| "... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..." | ||
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..." | ||
| Vol 5, No 1 (2009) | CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC | Abstract similar documents |
| I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov | ||
| "... diseases (CVD) in the Udmurt Republic (UR) of Russia. Material and methods. In prospective ..." | ||
| Vol 11, No 6 (2015) | The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev | ||
| "... .06); the presence of 2, 3, 4 and 5 comorbidities – respectively, by 4, 5, 6.4 and 13 times (p<0.001). The risk ..." | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 12, No 3 (2016) | CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 | Abstract PDF (Eng) similar documents |
| I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov | ||
| "... of effective cardiovascular disease (CVD) primary prevention. Such lesions include: arterial wall thickening ..." | ||
| Vol 14, No 2 (2018) | ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 | Abstract PDF (Eng) similar documents |
| A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov | ||
| "... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..." | ||
| Vol 16, No 1 (2020) | Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice | Abstract similar documents |
| M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov | ||
| "... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..." | ||
| Vol 11, No 5 (2015) | The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis | Abstract similar documents |
| S. A. Smetnev, A. N. Meshkov | ||
| "... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..." | ||
| Vol 12, No 2 (2016) | ВЗАИМОСВЯЗЬ МЕЖДУ РАЗЛИЧНЫМИ СТРУКТУРНО-ФУНКЦИОНАЛЬНЫМИ ХАРАКТЕРИСТИКАМИ СОСТОЯНИЯ АРТЕРИАЛЬНОЙ СТЕНКИ И ТРАДИЦИОННЫМИ ФАКТОРАМИ КАРДИОВАСКУЛЯРНОГО РИСКА У ЗДОРОВЫХ ЛЮДЕЙ РАЗНОГО ВОЗРАСТА. | Abstract similar documents |
| "... взаимосвязь наблюдается между ТКИМ и количеством АСБ: r=0,46 (р<0,001) в младшей группе и r=0,47 (р<0,001) в ..." | ||
| Vol 16, No 2 (2020) | Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development | Abstract similar documents |
| O. M. Drapkina, A. N. Kaburova | ||
| "... . In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still ..." | ||
| Vol 18, No 2 (2022) | Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... centuries. In the second part, the authors demonstrated that hostility/anger are a risk factor for the CVD ..." | ||
| Vol 13, No 4 (2017) | CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA | Abstract similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky | ||
| "... diseases (CVD) in the presence of limitations (chronic obstructive pulmonary disease – COPD ..." | ||
| Vol 11, No 5 (2015) | Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years | Abstract similar documents |
| A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk | ||
| "... . The incidence of cardiovascular diseases (CVDs) was determined according to the data from the medical ..." | ||
| Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
| "... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..." | ||
| Vol 12, No 6 (2016) | EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA | Abstract similar documents |
| S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev | ||
| "... lower in the group of vaccinated patients: by 36% (p=0.001) and by 59% (p=0.008), respectively ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... with cardiovascular diseases (CVD): hypertension and coronary artery disease (CАD) in comparison with healthy study ..." | ||
| Vol 20, No 5 (2024) | Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina | ||
| "... cardiovascular disease (CVD) who did not receive lipid-lowering therapy, participants of two independent ..." | ||
| Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
| M. Loukianov | ||
| "... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop ..." | ||
| Vol 15, No 2 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..." | ||
| Vol 18, No 6 (2022) | Predictors of Long-Term Outcomes after Surgical Myocardial Revascularization | Abstract similar documents |
| V. S. Kaveshnikov, M. A. Kuzmichkina, V. N. Serebryakova | ||
| "... High mortality from cardiovascular diseases (CVD) requires improved approaches to the treatment ..." | ||
| Vol 12, No 6 (2016) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)." Part 1. Hospital Prospective Register of Patients after Acute Stroke (According to the Results of the Pilot Phase of the Study) | Abstract similar documents |
| S. A. Boytsov, S. Yu. Martsevich, N. P. Kutishenko, M. M. Loukianov, A. E. Mitichkin, R. V. Viskov, L. V. Stakhovskaya, N. A. Shamalov, G. P. Arutyunov, I. V. Kokareva, N. E. Parsadanyan, M. I. Chernyshova, A. V. Zagrebelnyy, N. A. Dmitrieva, A. V. Akimova, G. I. Nikitina, O. V. Lerman, V. P. Voronina, E. N. Belova, E. N. Kudryashov, A. D. Deev | ||
| "... of the closest outpatient clinics). Presence of cardiovascular diseases (CVD) and their risk factors (RF ..." | ||
| Vol 19, No 3 (2023) | Plasma branched-chain amino acid concentrations in individuals without cardiovascular diseases versus patients diagnosed with hypertension and coronary artery disease | Abstract similar documents |
| M. V. Kozhevnikova, E. O. Korobkova, A. V. Krivova, A. V. Kukharenko, N. E. Moskaleva, K. M. Shestakova, N. V. Mesonzhnik, A. A. Ageev, A. A. Boldin, A. Brito, S. А. Appolonova, E. V. Privalova, Y. N. Belenkov | ||
| "... BCAAs (valine, leucine and isoleucine) in individuals without cardiovascular diseases (CVDs) (nonCVD ..." | ||
| Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
| "... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..." | ||
| Vol 16, No 3 (2020) | Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta | Abstract similar documents |
| R. N. Shepel, O. M. Drapkina | ||
| "... cardiovascular (CVD) and metabolic diseases. Although the current treatment strategy has improved survival ..." | ||
| Vol 16, No 6 (2020) | Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... with combination of 3-4 cardiovascular diseases (CVD), including AF (98.0% vs 81.7%, p<0.0001), and also ..." | ||
| Vol 19, No 5 (2023) | Relationship between parameters of subclinical atherosclerosis and osteoporosis and their prognostic significance: data from the prospective studies | Abstract similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, T. T. Tsoriev, O. Yu. Isaykina, O. M. Drapkina | ||
| "... We analyzed modern publications on the relationship between cardiovascular diseases (CVDs ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 18, No 6 (2022) | Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study | Abstract similar documents |
| F. T. Ageev, M. D. Smirnova | ||
| "... patients and in the analysis of subgroups according to the grade of hypertension (p<0.001 between visits ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... ) in patients with cardiovascular diseases (CVD) and hypercholesterolemia (HCS) in the Russian population ..." | ||
| Vol 14, No 3 (2018) | ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina | ||
| "... on local published studies. Local statistical data (2016) on cardio-vascular diseases (CVDs), including ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 19, No 2 (2023) | Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? | Abstract similar documents |
| A. M. Chaulin, D. V. Duplyakov | ||
| "... diseases (CVD). Therefore, considerable attention of researchers is focused on statins to study ..." | ||
| Vol 16, No 4 (2020) | From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases | Abstract similar documents |
| P. A. Lebedev, A. A. Garanin | ||
| "... as the most effective approach to the fight against cardiovascular diseases (CVD). The priority of domestic ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... ) of cardiovascular disease (CVD), duplex scanning of the common carotid arteries, transthoracic echocardiography ..." | ||
| Vol 1, No 1 (2005) | TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION | Abstract similar documents |
| O. V. Vikhireva, S. A. Shalnova, A. D. Deev | ||
| "... to quit smoking. To assess expected reduction of cardiovascular disease (CVD) and total mortality relative ..." | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively ..." | ||
| Vol 14, No 6 (2018) | Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov | ||
| "... diseases (CVD), compliance with the clinical recommendations of the prescribed and received drug therapy ..." | ||
| Vol 16, No 3 (2020) | Economic Burden of Hypertension in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. O. Myrzamatova, D. K. Mukaneeva, M. B. Khudyakov, O. M. Drapkina | ||
| "... of hypertension for cardiovascular diseases (CVD) (including stroke and coronary heart disease), chronic ..." | ||
| Vol 20, No 2 (2024) | The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age | Abstract similar documents |
| S. A. Shalnova, E. B. Yarovaya, V. A. Metelskaya, E. M. Filichkina, A. V. Kapustina, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, S. E. Evstifeeva, S. A. Maksimov, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, Yu. I. Grinshtein, R. A. Libis, O. P Rotar, I. A. Trubacheva, A. Yu. Efanov, S. S. Yakushin, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, A. O. Konradi, S. A. Boytsov, E. V Shlyakhto, O. M. Drapkina | ||
| "... for gender, age and region. There was a significantly higher risk of new cases of nonfatal CVD in individuals ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... group were older than these in the first group (p<0.001). Patients of the group 1 compared to the group ..." | ||
| Vol 14, No 5 (2018) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis | Abstract similar documents |
| D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova | ||
| "... (CVD). Inflammation plays a leading role in the development of CHF through various mechanisms including ..." | ||
| Vol 16, No 6 (2020) | Population-based Cardiovascular Disease Prevention Measures Aimed at Reducing Salt Intake: Analysis of International Strategies and Prospects for Implementation in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, N. S. Karamnova, D. K. Mukaneeva, O. M. Drapkina | ||
| "... High salt intake is an important risk factor for cardiovascular diseases (CVD), closely related ..." | ||
| Vol 17, No 3 (2021) | The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony | Abstract PDF (Eng) similar documents |
| S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... after PCI TSI improved significantly to 163.7±17.6 ms (p<0.001), 3 months after PCI showed more ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... (p<0.001), they were more often diagnosed with left ventricular aneurysm (p=0.001), chronic kidney ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... diseases (CVD), but also the prevention and treatment of chronic kidney disease (CKD). The fact ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.001) with a heredity ..." | ||
| Vol 13, No 1 (2017) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) | Abstract PDF (Eng) similar documents |
| S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev | ||
| "... , concomitant cardiovascular diseases (CVD) and noncardiac diseases were analyzed. We estimated accordance ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... -diastolic dimension (p<0,001), end-systolic dimension (p<0,001), left atrium (p=0,004), end-diastolic vol ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p<0.001), and flow rate ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... (CVD), but also increases the risk of overall mortality by 69% due to mortality from ..." | ||
| Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
| Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... .94%. One month after PCI, mean GLPSS improved significantly to -14.05±1.72% (p<0.001), 3 months after PCI ..." | ||
| Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
| "... of cardiovascular diseases [CVD]". The analysis of nonlinear associations was performed using the generalized ..." | ||
| Vol 17, No 5 (2021) | Social Network-Based Digital Stroke Prevention: Opportunities, Results and Prospects | Abstract PDF (Eng) similar documents |
| A. E. Demkina, M. V. Bezzubtseva, M. N. Ryabinina, Ya. A. Kotlyar, O. L. Keln, А. V. Sarapulova, R. R. Zhetishev, V. S. Kuvaev, M. Y. Maksimova, N. V. Pogosova, I. V. Zhetisheva | ||
| "... the stroke risk factors for diabetes mellitus, other cardiovascular diseases (CVD), obesity, and alcohol use ..." | ||
| Vol 20, No 6 (2024) | Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older | Abstract similar documents |
| S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, V. A. Kutsenko, Yu. A. Balanova, A. V. Kapustina, O. M. Drapkina | ||
| "... from CVD were registered. Results. A total of 1876 participants aged 55 years and older (48% men ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... diseases (CVD) in several regions of the Russian Federation with different climatic, geographic, economic ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... : +52.3%, p<0.001) in the main cohort and from 12.3% to 19.8% (+61.7%, p<0.001) in the additional cohort ..." | ||
| Vol 17, No 6 (2021) | Hyperuricemia: Features of the Diet | Abstract similar documents |
| O. B. Shvabskaia, O. V. Izmailova, N. S. Karamnova, O. M. Drapkina | ||
| "... The association of hyperuricemia (HU) with cardiovascular disease (CVD), diabetes, metabolic ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p<0.001), and size of the left atrium (LA; from ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... <0.001) were revealed. The right ventricle increased in size with the impairment of its diastolic ..." | ||
| Vol 12, No 6 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..." | ||
| Vol 12, No 1 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..." | ||
| Vol 7, No 5 (2011) | EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. M. Provotorov, S. A. Avdeeva | ||
| "... increase in hemoglobin (+12.5%; p<0.001) and hematocrit (+5.8%; p<0.001) levels, as well as increase in red ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.001), as well as the course ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..." | ||
| Vol 14, No 1 (2018) | ASSOCIATION OF RISK FACTORS FOR NON-COMMUNICABLE DISEASES WITH HEALTH CARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY ACCORDING TO DATA OF POPULATION STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
| E. I. Suvorova, S. A. Shalnova, A. V. Kontsevaya, A. D. Deev, A. V. Kapustina, Yu. A. Balanova | ||
| "... disability (TD) with the main risk factors (RF) for cardiovascular diseases (CVD) in working age population ..." | ||
| Vol 13, No 6 (2017) | ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES | Abstract similar documents |
| Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich | ||
| "... in the LIS-1 registry, more often took antiplatelet drugs (23.2% vs 15.7%, respectively; p<0.01) and statins ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... volume (p<0.01),right ventricle anterior-posterior dimension (p<0.001), right atrium volume (p<0.01 ..." | ||
| 1 - 100 of 442 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
